StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
77
This month
2
This year
9
Publishing Date
2024 - 03 - 05
2
2023 - 10 - 12
1
2023 - 10 - 10
1
2023 - 10 - 06
1
2023 - 10 - 05
1
2023 - 09 - 11
1
2023 - 09 - 07
1
2023 - 08 - 28
1
2023 - 08 - 08
1
2023 - 07 - 31
1
2023 - 06 - 21
1
2023 - 06 - 15
1
2023 - 06 - 06
1
2023 - 05 - 23
1
2023 - 05 - 08
1
2023 - 04 - 19
1
2023 - 04 - 18
1
2023 - 04 - 13
1
2023 - 01 - 06
1
2023 - 01 - 05
1
2022 - 12 - 12
1
2022 - 12 - 08
1
2022 - 10 - 06
1
2022 - 09 - 28
1
2022 - 09 - 27
1
2022 - 09 - 08
1
2022 - 08 - 08
1
2022 - 06 - 02
1
2022 - 05 - 19
2
2022 - 04 - 14
1
2022 - 04 - 08
1
2022 - 03 - 24
1
2022 - 03 - 23
1
2022 - 03 - 01
2
2022 - 02 - 22
1
2022 - 02 - 09
1
2022 - 01 - 24
1
2022 - 01 - 19
1
2022 - 01 - 18
1
2021 - 12 - 06
1
2021 - 11 - 23
1
2021 - 11 - 17
1
2021 - 11 - 09
1
2021 - 11 - 02
1
2021 - 10 - 28
2
2021 - 10 - 21
1
2021 - 10 - 18
1
2021 - 06 - 22
1
2021 - 06 - 07
1
2021 - 06 - 03
1
2021 - 05 - 13
1
2021 - 05 - 06
1
2021 - 04 - 13
1
2021 - 04 - 12
1
2021 - 04 - 09
1
2021 - 02 - 26
1
2021 - 02 - 08
1
2021 - 01 - 12
2
2020 - 12 - 04
1
2014 - 12 - 12
1
Sector
Communications
2
Health services
5
Health technology
63
Manufacturing
3
Non-energy minerals
1
Professional, scientific, and technical services
1
Retail trade
1
Tags
Acquisition
56
Agreement
49
Alliances
41
Application
43
Award
81
Awards
130
Biotech-bay
39
Brands
71
Business
56
Cancer
77
Care
44
Ceo
37
Ces
37
China
62
Collaboration
85
Companies
56
Conference
136
Designation
52
Device
32
Disease
36
Drug
66
Energy
97
Europe
52
Events
83
Financial
45
Global
253
Grant
38
Group
65
Growth
219
Health
116
Innovation
1023
International
52
Iot
36
Management
49
Market
331
Medical
55
Meeting
40
N/a
3595
Offering
35
One
35
Partnership
89
Patent
49
Platform
73
Program
50
Report
185
Research
188
Results
116
Services
44
Smart
37
Solution
46
Solutions
128
Study
46
System
59
Technology
304
Test
41
Therapeutics
57
Therapy
84
Treatment
117
Trial
69
Year
35
Entities
Abbott laboratories
1
Agenus inc.
1
Agilent technologies, inc.
2
Alkermes plc
3
Amgen inc.
2
Arvinas, inc.
1
Astellas pharma inc
1
Autonation, inc.
1
Bio-techne corp
1
Biolinerx ltd.
1
Boston scientific corporation
1
Briacell therapeutics corp.
1
Castle biosciences, inc.
1
Cohbar, inc.
1
Eli lilly and company
18
Evotec se
1
Exact sciences corporation
1
Femasys inc
1
Fulgent genetics, inc.
1
Galapagos nv
1
Hca healthcare, inc.
1
Hologic, inc.
1
Hoth therapeutics, inc.
1
Htg molecular diagnostics, inc.
1
Illumina, inc.
1
Incyte corporation
12
Inmune bio inc.
1
Intuitive surgical, inc.
1
Johnson & johnson
3
Kazia therapeutics limited
1
Koninklijke philips n.v.
3
Laboratory corporation of america holdings
2
Leap therapeutics, inc.
1
Mainz biomed b.v.
2
Merck & company, inc.
1
Merrimack pharmaceuticals, inc.
1
Myriad genetics, inc.
1
Nektar therapeutics
1
Novartis ag
2
Novocure limited
3
Nurix therapeutics, inc.
1
Opko health, inc.
1
Orange
2
Personalis, inc.
1
Pfizer, inc.
2
Phio pharmaceuticals corp.
1
Plus therapeutics, inc.
2
Posco
1
Quest diagnostics incorporated
1
Regeneron pharmaceuticals, inc.
1
Renovorx inc
6
Sanofi
11
Seagen inc.
1
Terumo corp
1
Thermo fisher scientific inc
1
Verastem, inc.
1
Volitionrx limited
1
Symbols
A
2
ABT
1
AGEN
1
ALKS
3
ALPMF
1
ALPMY
1
AMGN
2
AN
1
ARVN
1
BCTX
1
BLRX
1
BSX
1
CSTL
1
CWBR
1
DGX
1
EVOTF
1
EXAS
1
FEMY
1
FLGT
1
FNCTF
2
GLPG
1
GLPGF
1
HCA
1
HOLX
1
HOTH
1
HTGM
1
ILMN
1
INCY
12
INMB
1
ISRG
1
JNJ
3
KZIA
1
LH
2
LLY
18
LPTX
1
MACK
1
MRK
1
MYGN
1
MYNZ
2
NKTR
1
NRIX
1
NVCR
3
NVS
2
NVSEF
2
OPK
1
PFE
2
PHG
3
PHIO
1
PKX
1
PSNL
1
PSTV
2
REGN
1
RNXT
6
SGEN
1
SNY
11
SNYNF
11
TECH
1
TMO
1
TRUMF
1
TRUMY
1
Exchanges
Amex
1
Nasdaq
62
Nyse
33
Crawled Date
2024 - 03 - 05
2
2023 - 10 - 12
1
2023 - 10 - 10
1
2023 - 10 - 06
1
2023 - 10 - 05
1
2023 - 09 - 11
1
2023 - 09 - 07
1
2023 - 08 - 28
1
2023 - 08 - 08
1
2023 - 07 - 31
1
2023 - 06 - 21
1
2023 - 06 - 15
1
2023 - 06 - 06
1
2023 - 05 - 23
1
2023 - 05 - 08
1
2023 - 04 - 19
1
2023 - 04 - 18
1
2023 - 04 - 13
1
2023 - 01 - 06
1
2023 - 01 - 05
1
2022 - 12 - 12
1
2022 - 12 - 08
1
2022 - 10 - 06
1
2022 - 09 - 28
1
2022 - 09 - 27
1
2022 - 09 - 08
1
2022 - 08 - 08
1
2022 - 06 - 02
1
2022 - 05 - 19
2
2022 - 04 - 14
1
2022 - 04 - 08
1
2022 - 03 - 24
1
2022 - 03 - 23
1
2022 - 03 - 01
2
2022 - 02 - 22
1
2022 - 02 - 09
1
2022 - 01 - 24
1
2022 - 01 - 19
1
2022 - 01 - 18
1
2021 - 12 - 06
1
2021 - 11 - 23
1
2021 - 11 - 17
1
2021 - 11 - 10
1
2021 - 11 - 02
1
2021 - 10 - 28
2
2021 - 10 - 21
1
2021 - 10 - 18
1
2021 - 06 - 22
1
2021 - 06 - 07
1
2021 - 06 - 03
1
2021 - 05 - 13
1
2021 - 05 - 06
1
2021 - 04 - 13
2
2021 - 04 - 09
1
2021 - 03 - 21
1
2021 - 02 - 26
1
2021 - 02 - 08
1
2021 - 01 - 13
1
2021 - 01 - 12
1
2020 - 12 - 04
1
Crawled Time
00:00
5
00:11
1
01:00
7
02:00
2
03:00
1
05:00
1
06:00
3
06:03
1
08:00
2
09:00
3
10:00
1
11:00
6
12:00
8
12:20
3
12:26
1
12:30
2
13:00
6
13:15
3
13:20
1
13:30
1
14:00
4
14:30
1
15:00
4
15:30
1
16:00
1
16:12
1
19:00
2
20:00
2
21:00
2
22:00
1
Source
investor.alkermes.com
3
ir.biolinerx.com
1
renovorx.com
5
www.biospace.com
20
www.globenewswire.com
15
www.novocure.com
1
www.prnewswire.com
32
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
innovation
tags :
Cancer
save search
Galapagos showcases innovative approach in hematological cancer care with clinical and translational data presentations at EBMT congress 2024
Published:
2024-04-04
(Crawled : 20:00)
- globenewswire.com
GLPG
|
$29.075
0.57%
16K
|
Health Technology
|
-8.14%
|
O:
-0.47%
H:
1.14%
C:
0.47%
congress
cancer
care
Innovent and HUTCHMED Jointly Announce NDA Acceptance in China for Sintilimab Combination with Fruquintinib for the Treatment of Advanced Endometrial Cancer with Priority Review Status
Published:
2024-04-02
(Crawled : 05:00)
- prnewswire.com
LLY
|
$731.1
-1.99%
1M
|
Health Technology
|
-3.34%
|
O:
-2.79%
H:
1.32%
C:
1.18%
SNY
|
News
|
$46.34
2.09%
620K
|
Health Technology
|
-6.67%
|
O:
-1.14%
H:
0.02%
C:
-1.06%
review
cancer
treatment
advanced
china
Innovent Dosed First Participant in Phase 3 Clinical Study (Neoshot) of IBI310 (Anti-CTLA-4 Monoclonal Antibody) in Combination with Sintilimab for MSI-H/dMMR Colon Cancer Neoadjuvant Therapy
Published:
2024-03-27
(Crawled : 00:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
600K
|
Health Technology
|
-7.26%
|
O:
-0.26%
H:
0.0%
C:
0.0%
LLY
|
$731.1
-1.99%
1M
|
Health Technology
|
-3.11%
|
O:
0.49%
H:
0.84%
C:
-0.07%
SNY
|
News
|
$46.34
2.09%
620K
|
Health Technology
|
-7.5%
|
O:
1.06%
H:
0.0%
C:
0.0%
INCY
|
$52.6
-0.42%
380K
|
Health Technology
|
-6.6%
|
O:
-0.09%
H:
1.42%
C:
1.1%
ibi310
first
cancer
colon
therapy
study
Mainz Biomed Organizes HALLO DOC! Event to Highlight Innovations in Colorectal Cancer Treatment
Published:
2024-03-19
(Crawled : 12:00)
- globenewswire.com
MYNZ
|
$0.89
-1.55%
24K
|
|
-10.0%
|
O:
3.0%
H:
6.8%
C:
0.0%
cancer
treatment
High School Seniors Win $1.8 Million at Regeneron Science Talent Search 2024 for Innovative Scientific Research on Artificial Intelligence, Cancer Metabolism and Mathematical Optimization
Published:
2024-03-13
(Crawled : 02:00)
- globenewswire.com
REGN
|
$894.35
0.04%
140K
|
Health Technology
|
-7.15%
|
O:
0.95%
H:
0.0%
C:
-1.46%
million
cancer
research
Mainz Biomed Presents ColoAlert® at UDH Congress 2024: Leading the Way in Evidence-Based Cancer Screening Innovations
Published:
2024-03-12
(Crawled : 12:00)
- globenewswire.com
MYNZ
|
$0.89
-1.55%
24K
|
|
-15.09%
|
O:
3.77%
H:
3.64%
C:
-2.73%
coloalert
congress
cancer
AnHeart Therapeutics and Innovent Announce China’s NMPA has Accepted Second New Drug Application for Taletrectinib for First-Line Treatment of ROS1-Positive Lung Cancer
Published:
2024-03-05
(Crawled : 08:00)
- biospace.com/
SNY
|
News
|
$46.34
2.09%
620K
|
Health Technology
|
-3.17%
|
O:
1.17%
H:
0.0%
C:
0.0%
lung
drug
cancer
treatment
application
therapeutics
Innovent and AnHeart Therapeutics Announce the NMPA of China Has Accepted Second NDA for Taletrectinib for First-Line Treatment of ROS1-Positive Lung Cancer
Published:
2024-03-05
(Crawled : 06:00)
- prnewswire.com
SNY
|
News
|
$46.34
2.09%
620K
|
Health Technology
|
-3.17%
|
O:
1.17%
H:
0.0%
C:
0.0%
INCY
|
$52.6
-0.42%
380K
|
Health Technology
|
-11.55%
|
O:
0.4%
H:
0.38%
C:
-1.77%
lung
cancer
treatment
therapeutics
china
Antech launches breakthrough in-hospital innovation, Nu.Q® Canine Cancer Test
Published:
2024-01-12
(Crawled : 13:00)
- prnewswire.com
VNRX
|
$0.5999
-2.8%
150K
|
Health Technology
|
-26.19%
|
O:
1.74%
H:
15.59%
C:
14.66%
test
cancer
Innovent Presents Clinical Data Update of IBI351 (KRAS G12C Inhibitor) Monotherapy in Lung Cancer and Colorectal Cancer at ESMO Asia Congress 2023
Published:
2023-12-01
(Crawled : 06:00)
- biospace.com/
SNYNF
|
News
|
$92.7
600K
|
Health Technology
|
-0.06%
|
O:
1.39%
H:
0.0%
C:
-0.05%
SNY
|
News
|
$46.34
2.09%
620K
|
Health Technology
|
-1.26%
|
O:
0.93%
H:
0.0%
C:
0.0%
INCY
|
$52.6
-0.42%
380K
|
Health Technology
|
-2.8%
|
O:
0.15%
H:
0.35%
C:
-0.74%
ibi351
lung
congress
update
cancer
asia
Tigerlily Foundation and Labcorp Launch I AM INCLUDED Framework to Increase Clinical Trial Diversity, Accelerate Delivery of Innovative Cancer Treatments
Published:
2023-11-16
(Crawled : 12:00)
- prnewswire.com
LH
M
|
$200.03
0.29%
130K
|
Health Services
|
-4.74%
|
O:
0.49%
H:
0.0%
C:
-0.1%
cancer
trial
Transcatheter Embolization and Occlusion Devices Market Report 2023: Innovative Techniques and Rising Cancer Cases Drive Demand for TEO Devices
Published:
2023-11-06
(Crawled : 20:00)
- prnewswire.com
TRUMF
|
$16.928
1.9K
|
Health Technology
|
-39.27%
|
O:
-3.12%
H:
1.9%
C:
1.9%
TRUMY
|
$16.507
34K
|
Manufacturing
|
-41.42%
|
O:
0.46%
H:
0.0%
C:
-1.96%
BSX
|
$67.31
-0.16%
2.1M
|
Health Technology
|
27.67%
|
O:
-0.08%
H:
0.28%
C:
-1.14%
report
cancer
market
Pancreatic Cancer Diagnostics Market: Growing Prevalence of Pancreatic Cancer Drives Demand for Innovative Diagnostic Tools
Published:
2023-10-27
(Crawled : 16:00)
- prnewswire.com
TMO
|
News
|
$543.03
0.28%
300K
|
Health Technology
|
23.92%
|
O:
2.03%
H:
0.0%
C:
0.0%
LH
M
|
$200.03
0.29%
130K
|
Health Services
|
-2.89%
|
O:
-0.5%
H:
0.69%
C:
-2.89%
A
|
$133.1
0.5%
230K
|
Health Technology
|
31.15%
|
O:
0.22%
H:
0.23%
C:
-1.69%
ABT
|
News
|
$107.24
1.87%
2M
|
Health Technology
|
14.05%
|
O:
1.57%
H:
0.6%
C:
-2.01%
diagnostic
cancer
pancreatic
tools
growing
diagnostics
October is Breast Cancer Awareness Month – BriaCell is Leading the Fight with its Innovative Technology
Published:
2023-10-20
(Crawled : 13:30)
- globenewswire.com
BCTX
|
$2.19
-5.6%
-5.94%
140K
|
Professional, Scientific, and T...
|
-49.26%
|
O:
1.29%
H:
0.0%
C:
-6.72%
breast
cancer
technology
First U.S. Patients Undergo Innovative Brain Cancer Treatment in New Clinical Trial at HCA Healthcare’s Johnston-Willis Hospital
Published:
2023-10-12
(Crawled : 15:30)
- biospace.com/
HCA
4
|
$302.395
1.82%
460K
|
Health Services
|
27.43%
|
O:
0.25%
H:
0.36%
C:
-3.97%
hospital
cancer
treatment
trial
Merck Highlights Innovative Oncology Portfolio and Pipeline at ESMO Congress 2023 Underscoring Commitment to Advancing Cancer Research and Improving Patient Outcomes Across Multiple Stages of Disease
Published:
2023-10-10
(Crawled : 11:00)
- biospace.com/
MRK
|
$125.12
-0.09%
1.6M
|
Health Technology
|
19.97%
|
O:
-0.17%
H:
0.13%
C:
-0.68%
disease
congress
merck
cancer
pipeline
research
Global Next Generation Cancer Diagnostics Market Research Report 2023-2030: Key Players are Focusing on Innovative Product Launches and Geographical Expansion to Maintain their Competitive Edge
Published:
2023-10-06
(Crawled : 09:00)
- prnewswire.com
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-3.37%
|
O:
-0.72%
H:
0.0%
C:
-0.52%
NVS
|
$93.815
1.35%
410K
|
Health Technology
|
-3.19%
|
O:
0.95%
H:
0.41%
C:
0.08%
PHG
|
$20.065
0.43%
200K
|
Health Technology
|
2.23%
|
O:
-9.44%
H:
2.86%
C:
2.46%
A
|
$133.1
0.5%
230K
|
Health Technology
|
22.68%
|
O:
-1.81%
H:
2.08%
C:
1.05%
OPK
|
$1.235
0.41%
610K
|
Health Technology
|
-18.54%
|
O:
-1.32%
H:
2.68%
C:
2.01%
MYGN
F
|
$18.43
-0.43%
61K
|
Health Technology
|
20.34%
|
O:
-0.97%
H:
4.4%
C:
-0.59%
ILMN
|
$117.82
0.97%
560K
|
Health Technology
|
-15.16%
|
O:
-1.36%
H:
2.95%
C:
1.8%
report
cancer
expansion
research
global
diagnostics
market
Novartis to present new oncology data at ESMO 2023 demonstrating practice-changing innovation in advanced prostate and early breast cancer
Published:
2023-10-05
(Crawled : 06:00)
- globenewswire.com
NVS
|
$93.815
1.35%
410K
|
Health Technology
|
-3.25%
|
O:
-1.21%
H:
1.3%
C:
1.16%
breast
innovation
cancer
novartis
Plus Therapeutics Receives $1.9 Million Advance Payment from CPRIT and Plans to Present at the CPRIT Innovations in Cancer Prevention and Research Conference
Published:
2023-09-11
(Crawled : 11:00)
- globenewswire.com
PSTV
|
$1.67
-1.27%
1.9K
|
Health Technology
|
22.46%
|
O:
14.49%
H:
24.05%
C:
-5.06%
conference
payment
cancer
research
therapeutics
plus
Nurix Announces Strategic Collaboration with Seagen Combining Industry Leading Technologies of Targeted Protein Degradation and Antibody-Drug Conjugation to Advance an Innovative New Class of Cancer Therapeutics
Published:
2023-09-07
(Crawled : 11:00)
- globenewswire.com
SGEN
|
$228.74
0.1%
20M
|
Health Technology
|
10.34%
|
O:
-0.55%
H:
0.2%
C:
-0.62%
NRIX
2 d
|
$14.215
-1.56%
110K
|
Health Technology
|
76.31%
|
O:
8.91%
H:
6.28%
C:
0.67%
cancer
protein
collaboration
therapeutics
← Previous
1
2
3
4
Next →
Gainers vs Losers
79%
21%
Top 10 Gainers
AGBA
|
News
|
$1.22
205.0%
86M
|
Finance
EGOX
|
$0.0606
68.33%
250M
|
NVFY
|
$3.45
63.51%
20M
|
Consumer Durables
CHRO
|
$1.66
35.51%
70K
|
n/a
INDO
|
$5.43
33.09%
10M
|
Energy Minerals
ZCMD
|
$1.86
28.28%
29M
|
Commercial Services
PAPL
|
$2.07
26.22%
550K
|
RWOD
|
$10.08
26.05%
5.6M
|
n/a
AULT
|
$0.3022
24.82%
51M
|
Manufacturing
HUSA
4
|
$2.07
23.95%
2.1M
|
Energy Minerals
Your saved searches
Save your searches and get alerts when important news are released.